Cargando…
PLGA-modified Syloid(®)-based microparticles for the ocular delivery of terconazole: in-vitro and in-vivo investigations
The eye is an invulnerable organ with intrinsic anatomical and physiological barriers, hindering the development of a pioneer ocular formulation. The aim of this work was to develop an efficient ocular delivery system that can augment the ocular bioavailability of the antifungal drug, terconazole. M...
Autores principales: | Zaghloul, Nada, Mahmoud, Azza A., Elkasabgy, Nermeen A., El Hoffy, Nada M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291711/ https://www.ncbi.nlm.nih.gov/pubmed/35838555 http://dx.doi.org/10.1080/10717544.2022.2092239 |
Ejemplares similares
-
Cyclodextrin Stabilized Freeze-Dried Silica/Chitosan Nanoparticles for Improved Terconazole Ocular Bioavailability
por: Zaghloul, Nada, et al.
Publicado: (2022) -
Self-nanoemulsifying System Optimization for Higher Terconazole Solubilization and Non-Irritant Ocular Administration
por: Yousry, Carol, et al.
Publicado: (2020) -
Repurposing of terconazole as an anti Trypanosoma cruzi agent
por: Reigada, Chantal, et al.
Publicado: (2019) -
Enhancing the dissolution of phenylbutazone using Syloid® based mesoporous silicas for oral equine applications
por: Waters, Laura J., et al.
Publicado: (2018) -
Preclinical Development and In Vivo Efficacy of Ceftiofur-PLGA Microparticles
por: Vilos, Cristian, et al.
Publicado: (2015)